• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WATCHMAN LAA CLOSURE DEVICE & DELIVERY SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WATCHMAN LAA CLOSURE DEVICE & DELIVERY SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL Back to Search Results
Model Number 10371
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Stroke/CVA (1770); Transient Ischemic Attack (2109); Thrombosis/Thrombus (4440)
Date of Event 12/25/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Date of event and explant date: estimated based on the event occurring the following weekend after implant.
 
Event or Problem Description
It was reported that thrombosis and a cerebral vascular accident occurred.A left atrial appendage (laa) closure procedure was performed and a 30mm watchman laa closure device was implanted.The following weekend, the patient presented to the emergency room with stroke-like symptoms.A transesophageal echo (tee) showed a large thrombus on the device.Surgical intervention as performed to remove the clot and the watchman device was subsequently explanted and the laa was ligated.
 
Additional Manufacturer Narrative
B3 event date, d6b explant date, and h6 patient codes corrected.
 
Event or Problem Description
It was reported that thrombosis and a cerebral vascular accident occurred.A left atrial appendage (laa) closure procedure was performed and a 30mm watchman laa closure device was implanted.The following weekend, the patient presented to the emergency room with stroke-like symptoms.A transesophageal echo (tee) showed a large thrombus on the device.Surgical intervention as performed to remove the clot and the watchman device was subsequently explanted and the laa was ligated.It was further reported that a transient ischemic attack occurred and not a cerebral vascular accident.At the time of the event the patient was on novel oral anticoagulants (noac).The patient has been discharged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WATCHMAN LAA CLOSURE DEVICE & DELIVERY SYSTEM
Common Device Name
SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key11270102
Report Number2134265-2021-00991
Device Sequence Number4607265
Product Code NGV
UDI-Device Identifier08714729838258
UDI-Public08714729838258
Combination Product (Y/N)N
Initial Reporter StateTN
Initial Reporter CountryUS
PMA/510(K) Number
P130013
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Device Explanted Year2020
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/30/2023
Device Model Number10371
Device Catalogue Number10371
Device Lot Number0025134719
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 01/13/2021
Supplement Date Received by Manufacturer02/02/2021
Initial Report FDA Received Date02/02/2021
Supplement Report FDA Received Date02/19/2021
Patient Sequence Number1
Outcome Attributed to Adverse Event Other; Required Intervention;
-
-